NL-OMON41181
Not yet recruiting
Not Applicable
Sentinel node biopsy for bladder cancer using the hybrid tracer - Hybrid sentinel node biopsy for bladder cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bladder cancer
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients \>18 years with clinically localized bladder cancer
- •Patients with proven histological\-pathological bladder cancer
- •Patients scheduled for brachytherapy or radical cystectomy with or without neo\-adjuvant chemotherapy
- •Patients with cN0 lymph node status
Exclusion Criteria
- •Patients with preoperatively known distant metastases (M1\);
- •Patients with clinically tumor positive nodes;
- •Previous radiation therapy of the pelvis;
- •Previous pelvic lymphadenectomy for other reasons such as urologic and gynecologic malignancies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Bladder cancer sentinel node mapping using ICG-99mTc-nanocolloidBladder cancerBladder carcinomaNL-OMON21640The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands30
Not yet recruiting
Not Applicable
Diagnosis of bladder cancer using probe-based confocal laser endomicroscopyBladder CancerJPRN-UMIN000021067Depatment of Urology, Kyoto Prefectural University of Medicine50
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
Completed
Phase 2
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227